Repository logo
 

The Cell-Surface Marker Sushi Containing Domain 2 Facilitates Establishment of Human Naive Pluripotent Stem Cells.

Accepted version
Peer-reviewed

Type

Article

Change log

Authors

Bredenkamp, Nicholas 
Stirparo, Giuliano Giuseppe 
Guo, Ge 

Abstract

Recently naive human pluripotent stem cells (hPSCs) have been described that relate to an earlier stage of development than conventional hPSCs. Naive hPSCs remain challenging to generate and authenticate, however. Here we report that Sushi Containing Domain 2 (SUSD2) is a robust cell-surface marker of naive hPSCs in the embryo and in vitro. SUSD2 transcripts are enriched in the pre-implantation epiblast of human blastocysts and immunostaining shows localization of SUSD2 to KLF17-positive epiblast cells. SUSD2 mRNA is strongly expressed in naive hPSCs but is negligible in other hPSCs. SUSD2 immunostaining of live or fixed cells provides unambiguous discrimination of naive versus conventional hPSCs. SUSD2 staining or flow cytometry enable monitoring of naive hPSCs in maintenance culture, and their isolation and quantification during resetting of conventional hPSCs or somatic cell reprogramming. Thus SUSD2 is a powerful non-invasive tool for reliable identification and purification of the naive hPSC phenotype.

Description

Keywords

SUSD2, cell-surface marker, chemical resetting, human naive pluripotent stem cell, somatic cell reprogramming, Antigens, Differentiation, Blastocyst, Cell Line, Cell Separation, Cellular Reprogramming Techniques, Germ Layers, Humans, Membrane Glycoproteins, Pluripotent Stem Cells, Transcription Factors

Journal Title

Stem Cell Reports

Conference Name

Journal ISSN

2213-6711
2213-6711

Volume Title

12

Publisher

Elsevier BV

Rights

All rights reserved
Sponsorship
European Commission (602423)
Medical Research Council (MR/P00072X/1)
Medical Research Council (G1001028)
This research was funded by the Medical Research Council of the United Kingdom (G1001028 and MR/P00072X/1) and European Commission Framework 7 (HEALTH-F4-2013-602423, PluriMes). The Cambridge Stem Cell Institute receives core support from the Wellcome Trust and the Medical Research Council. AS is a Medical Research Council Professor.